ImmunoGen, Inc. Quarterly Other Assets, Noncurrent in USD from Q2 2011 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of noncurrent assets classified as other.
Summary
ImmunoGen, Inc. quarterly Other Assets, Noncurrent history and growth rate from Q2 2011 to Q3 2023.
  • ImmunoGen, Inc. Other Assets, Noncurrent for the quarter ending September 30, 2023 was $14.2M, a 8.08% increase year-over-year.
Other Assets, Noncurrent, Quarterly (USD)
Other Assets, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2023 $14.2M +$1.06M +8.08% Sep 30, 2023 10-Q 2023-11-02
Q2 2023 $14.3M +$1.62M +12.8% Jun 30, 2023 10-Q 2023-07-31
Q1 2023 $14.5M +$5.82M +67.2% Mar 31, 2023 10-Q 2023-04-28
Q4 2022 $14M +$5.3M +60.8% Dec 31, 2022 10-Q 2023-11-02
Q3 2022 $13.1M +$4.57M +53.5% Sep 30, 2022 10-Q 2022-11-04
Q2 2022 $12.7M +$3.79M +42.7% Jun 30, 2022 10-Q 2022-08-01
Q1 2022 $8.67M +$1.35M +18.4% Mar 31, 2022 10-Q 2022-05-06
Q4 2021 $8.71M -$2.28M -20.7% Dec 31, 2021 10-K 2023-03-01
Q3 2021 $8.54M -$35K -0.41% Sep 30, 2021 10-Q 2021-10-29
Q2 2021 $8.89M +$1.3M +17.1% Jun 30, 2021 10-Q 2021-07-30
Q1 2021 $7.33M +$494K +7.23% Mar 31, 2021 10-Q 2021-05-10
Q4 2020 $11M +$7.2M +190% Dec 31, 2020 10-K 2022-02-28
Q3 2020 $8.57M +$5.16M +151% Sep 30, 2020 10-Q 2020-11-06
Q2 2020 $7.59M +$5.74M +310% Jun 30, 2020 10-Q 2020-08-05
Q1 2020 $6.83M +$3.17M +86.4% Mar 31, 2020 10-Q 2020-05-05
Q4 2019 $3.78M +$75K +2.02% Dec 31, 2019 10-K 2021-03-01
Q3 2019 $3.41M -$528K -13.4% Sep 30, 2019 10-Q 2019-11-05
Q2 2019 $1.85M -$2.59M -58.3% Jun 30, 2019 10-Q 2019-08-07
Q1 2019 $3.67M -$1.02M -21.7% Mar 31, 2019 10-Q 2019-05-07
Q4 2018 $3.71M -$88K -2.32% Dec 31, 2018 10-K 2020-03-11
Q3 2018 $3.94M +$828K +26.6% Sep 30, 2018 10-Q 2018-11-02
Q2 2018 $4.44M +$1.29M +40.9% Jun 30, 2018 10-Q 2018-08-03
Q1 2018 $4.68M +$1.49M +46.6% Mar 31, 2018 10-Q 2018-05-09
Q4 2017 $3.8M +$777K +25.7% Dec 31, 2017 10-K 2019-03-01
Q3 2017 $3.11M -$20K -0.64% Sep 30, 2017 10-Q 2017-11-09
Q2 2017 $3.15M -$282K -8.22% Jun 30, 2017 10-Q 2017-08-04
Q1 2017 $3.19M +$268K +9.16% Mar 31, 2017 10-Q 2017-05-05
Q4 2016 $3.02M +$78K +2.65% Dec 31, 2016 10-K 2018-03-07
Q3 2016 $3.13M +$2.22M +244% Sep 30, 2016 10-Q 2016-11-04
Q2 2016 $3.43M +$2.46M +252% Jun 30, 2016 10-KT 2017-03-03
Q1 2016 $2.93M +$2.88M +6702% Mar 31, 2016 10-Q 2016-05-04
Q4 2015 $2.94M +$2.89M +5904% Dec 31, 2015 10-Q 2016-02-04
Q3 2015 $911K +$803K +744% Sep 30, 2015 10-Q 2015-10-30
Q2 2015 $974K +$761K +357% Jun 30, 2015 10-KT 2017-03-03
Q1 2015 $43K -$349K -89% Mar 31, 2015 10-Q 2015-05-08
Q4 2014 $49K -$351K -87.8% Dec 31, 2014 10-Q 2015-02-05
Q3 2014 $108K -$95K -46.8% Sep 30, 2014 10-Q 2014-10-30
Q2 2014 $213K -$4K -1.84% Jun 30, 2014 10-K 2015-08-27
Q1 2014 $392K +$209K +114% Mar 31, 2014 10-Q 2014-05-02
Q4 2013 $400K +$204K +104% Dec 31, 2013 10-Q 2014-02-05
Q3 2013 $203K +$29K +16.7% Sep 30, 2013 10-Q 2013-10-29
Q2 2013 $217K +$43K +24.7% Jun 30, 2013 10-K 2014-08-28
Q1 2013 $183K -$33K -15.3% Mar 31, 2013 10-Q 2013-05-06
Q4 2012 $196K +$55K +39% Dec 31, 2012 10-Q 2013-01-30
Q3 2012 $174K +$33K +23.4% Sep 30, 2012 10-Q 2012-10-31
Q2 2012 $174K +$16K +10.1% Jun 30, 2012 10-K 2013-08-29
Q1 2012 $216K Mar 31, 2012 10-Q 2012-05-10
Q4 2011 $141K Dec 31, 2011 10-Q 2012-01-31
Q3 2011 $141K Sep 30, 2011 10-Q 2011-10-31
Q2 2011 $158K Jun 30, 2011 10-K 2012-08-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.